Shoji Kensuke, Funaki Takanori, Kasahara Mureo, Sakamoto Seisuke, Fukuda Akinari, Vaida Florin, Ito Kenta, Miyairi Isao, Saitoh Akihiko
From the *Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; †Transplantation Center, National Center for Child Health and Development, Tokyo, Japan; ‡Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla; §Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and ‖Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego, La Jolla.
Pediatr Infect Dis J. 2015 Oct;34(10):1063-8. doi: 10.1097/INF.0000000000000811.
Postoperative bloodstream infection (BSI) is the most important determinant of recipient morbidity and mortality after liver transplantation (LT). Children who underwent LT are at the highest risk of developing BSI because of the significant surgical intervention, use of multiple devices, and administration of immunosuppressive agents. However, information regarding the risk factors for BSI in children after LT is limited.
We retrospectively reviewed 210 children who underwent living-donor LT at the largest pediatric LT center in Japan. Patients' characteristics, blood culture results and clinical outcomes were extracted from electronic medical records. Univariate and multivariate analyses were performed to identify the risk factors for BSI.
Among the 210 LT recipients, 53 (25%) recipients experienced 86 episodes of BSI during the observational period. The source of the BSI was identified only in 38%: catheter-related BSI (27%) peritonitis (7%), urinary tract infection (2%), pneumonia (1%) and infectious endocarditis (1%). A multivariate analysis demonstrated that body weight (P = 0.03), volume of blood loss during LT (P < 0.001) and cytomegalovirus (CMV) antigenemia positivity (P = 0.04) were independently associated with the development of BSI. The risk factors for BSI differed when we analyzed the subjects according to age (≤24 months and >24 months), blood loss and pediatric end-stage liver disease/model for end-stage liver disease versus positive CMV antigenemia.
The volume of blood loss, postoperative CMV antigenemia positivity and body weight were associated with the development of BSI after LT in pediatric living-donor recipients. To identify the age-specific predictors of BSI in children who underwent LT, age-specific analyses are crucial.
术后血流感染(BSI)是肝移植(LT)后受者发病和死亡的最重要决定因素。接受LT的儿童由于重大手术干预、多种设备的使用以及免疫抑制剂的应用,发生BSI的风险最高。然而,关于LT后儿童BSI危险因素的信息有限。
我们回顾性分析了日本最大的儿科LT中心210例接受活体肝移植的儿童。从电子病历中提取患者特征、血培养结果和临床结局。进行单因素和多因素分析以确定BSI的危险因素。
在210例LT受者中,53例(25%)在观察期内发生了86次BSI发作。仅在38%的病例中确定了BSI的来源:导管相关BSI(27%)、腹膜炎(7%)、尿路感染(2%)、肺炎(1%)和感染性心内膜炎(1%)。多因素分析表明,体重(P = 0.03)、LT期间失血量(P < 0.001)和巨细胞病毒(CMV)抗原血症阳性(P = 0.04)与BSI的发生独立相关。当我们根据年龄(≤24个月和>24个月)、失血量以及儿童终末期肝病/终末期肝病模型与CMV抗原血症阳性进行分析时,BSI的危险因素有所不同。
失血量、术后CMV抗原血症阳性和体重与小儿活体肝移植受者LT后BSI的发生有关。为了确定接受LT的儿童中BSI的年龄特异性预测因素,特定年龄的分析至关重要。